CLBT logo

Cellebrite DI Ltd. Stock Price

NasdaqGS:CLBT Community·US$3.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 42 Fair Values set on narratives written by author

CLBT Share Price Performance

US$12.83
-2.64 (-17.07%)
US$21.00
Fair Value
US$12.83
-2.64 (-17.07%)
38.9% undervalued intrinsic discount
US$21.00
Fair Value
Price US$12.83
AnalystConsensusTarget US$21.00
AnalystLowTarget US$15.00
AnalystHighTarget US$28.00

CLBT Community Narratives

·
Fair Value US$21 38.9% undervalued intrinsic discount

Cloud SaaS Solutions Will Drive Digital Forensics Adoption

1users have liked this narrative
0users have commented on this narrative
19users have followed this narrative
·
Fair Value US$15 14.5% undervalued intrinsic discount

Government Delays Will Limit Digital Forensics Efficacy But Boost Resilience

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$28 54.2% undervalued intrinsic discount

Digital Device Growth And Cybercrime Will Transform Investigations

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$15
14.5% undervalued intrinsic discount
Revenue
17.4% p.a.
Profit Margin
15.36%
Future PE
41.51x
Price in 2029
US$20.28
US$21
38.9% undervalued intrinsic discount
Revenue
17.4% p.a.
Profit Margin
16.97%
Future PE
52.48x
Price in 2029
US$28.32
US$28
54.2% undervalued intrinsic discount
Profit Margin
28.14%
Future PE
54.88x
Price in 2028
US$37.88

Trending Discussion

Updated Narratives

CLBT logo

CLBT: AI Evidence Platform And Cloud Authorizations Will Shape Earnings Power

Fair Value: US$15 14.5% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CLBT logo

CLBT: Federal AI And Cloud Adoption Will Support Premium P/E Potential

Fair Value: US$21 38.9% undervalued intrinsic discount
19 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CLBT logo

Digital Device Growth And Cybercrime Will Transform Investigations

Fair Value: US$28 54.2% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

0 Risks
3 Rewards

Cellebrite DI Ltd. Key Details

US$496.4m

Revenue

US$80.1m

Cost of Revenue

US$416.3m

Gross Profit

US$345.0m

Other Expenses

US$71.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.29
83.86%
14.37%
0%
View Full Analysis

About CLBT

Founded
n/a
Employees
1285
CEO
Thomas Hogan
WebsiteView website
www.cellebrite.com

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

Recent CLBT News & Updates

Seeking Alpha Jun 12

Cellebrite: Stronger Fundamentals Support A Buy Rating

Summary Cellebrite remains a buy as fundamentals strengthen, with FedRAMP High achieved and federal demand reaccelerating. Q2 ARR guidance of $510–513M implies 22–23% growth, supporting a narrative of renewed momentum post-federal softness. Platform adoption advances, with Inseyets conversions near 60% and growth products now 14% of ARR, lengthening CLBT’s growth runway. AI-driven Genesis offers real but unmodeled optionality; valuation upside exists if execution and new product monetization deliver. Read the full article on Seeking Alpha

Recent updates

No updates